BUMETANIDE AND FUROSEMIDE

被引：61

作者：

BRATER, DC ^{[1
]}

CHENNAVASIN, P ^{[1
]}

DAY, B ^{[1
]}

BURDETTE, A ^{[1
]}

ANDERSON, S ^{[1
]}

机构：

[1] UNIV TEXAS, HLTH SCI CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA

来源：

关键词：

D O I：

10.1038/clpt.1983.154

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：207 / 213

页数：7

共 25 条

[1] PHARMACOKINETICS-PHARMACODYNAMICS OF FUROSEMIDE IN MAN - REVIEW
BENET, LZ
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (01): : 1 - 27
[2] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS
BOXENBAU.HG
RIEGELMA.S
ELASHOFF, RM
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02): : 123 - 148
[3] ABSORPTION AND DISPOSITION OF FUROSEMIDE IN CONGESTIVE HEART-FAILURE
BRATER, DC
SEIWELL, R
ANDERSON, S
BURDETTE, A
DEHMER, GJ
CHENNAVASIN, P
[J]. KIDNEY INTERNATIONAL, 1982, 22 (02) : 171 - 176
[4] VARIABILITY IN DERIVED PARAMETERS OF FUROSEMIDE PHARMACOKINETICS
CHENNAVASIN, P
JOHNSON, RA
BRATER, DC
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (05): : 623 - 633
[5] CHENNAVASIN P, 1980, J PHARMACOL EXP THER, V215, P77
[6] PHARMACODYNAMIC ANALYSIS OF THE FUROSEMIDE-PROBENECID INTERACTION IN MAN
CHENNAVASIN, P
SEIWELL, R
BRATER, DC
LIANG, WMM
[J]. KIDNEY INTERNATIONAL, 1979, 16 (02) : 187 - 195
[7] CLINICAL PHARMACOKINETICS OF FRUSEMIDE
CUTLER, RE
BLAIR, AD
[J]. CLINICAL PHARMACOKINETICS, 1979, 4 (04) : 279 - 296
[8] DAVIES DL, 1974, CLIN PHARMACOL THER, V15, P141
[9] PHARMACOKINETICS OF FUROSEMIDE IN PATIENTS WITH CONGESTIVE HEART-FAILURE
GREITHER, A
GOLDMAN, S
EDELEN, JS
BENET, LZ
COHN, K
[J]. PHARMACOLOGY, 1979, 19 (03) : 121 - 131
[10] HALLADAY SC, 1977, CLIN PHARMACOL THER, V22, P179